Reactivating the ARF-p53 axis in AML cells by targeting ULF

References

• Vousden KH, Lane DP. p53 in health and disease. Nat Rev Mol Cell Biol 2007; 8:275 - 283
   PubMed Web of Science ®Google Scholar
• Michael D, Oren M. The p53-Mdm2 module and the ubiquitin system. Semin in Cancer Biol 2003; 13:49 - 58
   PubMed Web of Science ®Google Scholar
• Kruse JP, Gu W. Modes of p53 regulation. Cell 2009; 137:609 - 622
   PubMed Web of Science ®Google Scholar
• Sherr CJ. Divorcing ARF and p53: an unsettled case. Nat Rev Cancer 2006; 6:663 - 673
   PubMed Web of Science ®Google Scholar
• Saporita AJ, Maggi LB, Apicelli AJ, Weber JD. Therapeutic targets in the ARF tumor suppressor pathway. Curr Med Chem 2007; 14:1815 - 1827
   PubMed Web of Science ®Google Scholar
• Matheu A, Maraver A, Serrano M. The Arf/p53 pathway in cancer and aging. Cancer Res 2008; 68:6031 - 6034
   PubMed Web of Science ®Google Scholar
• Martins CP, Brown-Swigart L, Evan GI. Modeling the therapeutic efficacy of p53 restoration in tumors. Cell 2006; 127:1323 - 1334
   PubMed Web of Science ®Google Scholar
• Quelle DE, Zindy F, Ashmun RA, Sherr CJ. Alternative Reading Frames Of The Ink4a Tumor-Suppressor Gene Encode 2 Unrelated Proteins Capable Of Inducing Cell-Cycle Arrest. Cell 1995; 83:993 - 1000
   PubMed Web of Science ®Google Scholar
• Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D. Nucleolar Arf sequesters Mdm2 and activates p53. Nat Cell Biol 1999; 1:20 - 26
   PubMed Web of Science ®Google Scholar
• Llanos S, Clark PA, Rowe J, Peters G. Stabilization of p53 by p14(ARF) without relocation of MDM2 to the nucleolus. Nat Cell Biol 2001; 3:445 - 452
   PubMed Web of Science ®Google Scholar
• Honda R, Yasuda H. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J 1999; 18:22 - 27
   PubMed Web of Science ®Google Scholar
• Midgley CA, Desterro JM, Saville MK, Howard S, Sparks A, Hay RT, Lane DP. An N-terminal p14(ARF) peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo. Oncogene 2000; 19:2312 - 2323
   PubMed Web of Science ®Google Scholar
• Chen D, Kon N, Li M, Zhang W, Qin J, Gu W. ARF-BP1/mule is a critical mediator of the ARF tumor suppressor. Cell 2005; 121:1071 - 1083
   PubMed Web of Science ®Google Scholar
• Lowe SW, Sherr CJ. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr Opin Genet Dev 2003; 13:77 - 83
   PubMed Web of Science ®Google Scholar
• Kuo ML, den Besten W, Bertwistle D, Roussel MF, Sherr CJ. N-terminal polyubiquitination and degradation of the Arf tumor suppressor. Genes Dev 2004; 18:1862 - 1874
   PubMed Web of Science ®Google Scholar
• Chen D, Shan J, Zhu WG, Qin J, Gu W. Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses. Nature 2010; 464:624 - 627
   PubMed Web of Science ®Google Scholar
• Bertwistle D, Sugimoto M, Sherr CJ. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23. Mol Cell Biol 2004; 24:985 - 996
   PubMed Web of Science ®Google Scholar
• Moulin S, Llanos S, Kim SH, Peters G. Binding to nucleophosmin determines the localization of human and chicken ARF but not its impact on p53. Oncogene 2008; 27:2382 - 2389
   PubMed Web of Science ®Google Scholar
• Colombo E, Bonetti P, Lazzerini Denchi E, Martinelli P, Zamponi R, Marine JC, et al. Nucleophosmin is required for DNA integrity and p19(Arf) protein stability. Mol Cell Biol 2005; 25:8874 - 98886
   PubMed Web of Science ®Google Scholar
• Colombo E, Martinelli P, Zamponi R, Shing DC, Bonetti P, Luzi L, et al. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant. Cancer Res 2006; 66:3044 - 3050
   PubMed Web of Science ®Google Scholar
• den Besten W, Kuo ML, Williams RT, Sherr CJ. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumour suppressor protein. Cell Cycle 2005; 4:1593 - 1598
   PubMed Web of Science ®Google Scholar
• Cheng K, Grisendi S, Clohessy JG, Majid S, Bernardi R, Sportoletti P, et al. The leukemia-associated cytoplasmic nucleophosmin mutant is an oncogene with paradoxical functions: Arf inactivation and induction of cellular senescence. Oncogene 2007; 26:7391 - 7400
   PubMed Web of Science ®Google Scholar
• Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L, et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. NEJM 2005; 352:254 - 266
   PubMed Web of Science ®Google Scholar
• Quentmeier H, Martelli MP, Dirks WG, Bolli N, Liso A, Macleod RA, et al. Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin. Leukemia 2005; 19:1760 - 1767
   PubMed Web of Science ®Google Scholar
• Lindstrom MS, Zhang YP. B23 and ARF—Friends or foes?. Cell Biochem Biophy 2006; 46:79 - 90
   PubMed Web of Science ®Google Scholar
• Park Y, Yoon SK, Yoon JB. The HECT domain of Trip12 ubiquitinates substrates of the ubiquitin fusion degradation pathway. J Biol Chem 2009; 284:1540 - 1549
   PubMed Web of Science ®Google Scholar
• Feuerstein N, Mond JJ. “Numatrin,” A Nuclear Matrix Protein Associated With Induction Of Proliferation In Lymphocytes-B. J Biol Chem 1987; 262:11389 - 11397
   PubMed Web of Science ®Google Scholar
• Nozawa Y, vanBelzen N, vanderMade ACJ, Dinjens WNM, Bosman FT. Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa. J Pathol 1996; 178:48 - 52
   PubMed Web of Science ®Google Scholar
• Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev 1998; 12:2424 - 2433
   PubMed Web of Science ®Google Scholar
• Grisendi S, Mecucci C, Falini B, Pandolfi PP. Nucleophosmin and cancer. Nat Rev Cancer 2006; 6:493 - 505
   PubMed Web of Science ®Google Scholar
• Rego EM, Ruggero D, Tribioli C, Cattoretti G, Kogan S, Redner RL, et al. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha. Oncogene 2006; 25:1974 - 1979
   PubMed Web of Science ®Google Scholar
• Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D. Germline transmission and tissure-specific expression of transgenes delivered by lentiviral vectors. Science 2002; 295:868 - 872
   PubMed Web of Science ®Google Scholar